Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,24233,992,1.01 [0.94-1.09],0.6892909028160913
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24154,198,0.96 [0.82-1.13],0.6180533337506274
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,26179,191,0.94 [0.80-1.11],0.4748692622540296
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18480,770,1.02 [0.94-1.11],0.6539426048787269
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26112,124,0.83 [0.67-1.01],0.0663939312900125
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25032,85,0.97 [0.76-1.23],0.7958799013671178
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27551,123,0.83 [0.68-1.02],0.0807391081813279
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27545,83,0.89 [0.70-1.14],0.3731521777316978
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24399,66,1.07 [0.82-1.41],0.6192672628108168
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,26871,121,1.01 [0.82-1.23],0.950522282499171
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26822,72,0.97 [0.75-1.27],0.8494783539290275
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27627,77,1.05 [0.82-1.35],0.6988286360293232
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27594,102,1.00 [0.80-1.24],0.9971465557800916
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27589,97,1.01 [0.81-1.27],0.8987175445166927
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Mycoses,27245,65,0.91 [0.69-1.20],0.5118929752661447
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26426,437,1.06 [0.96-1.18],0.2459779790965091
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26120,131,1.10 [0.91-1.33],0.3297517628828205
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26292,303,1.10 [0.97-1.25],0.1345734858882988
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",22603,49,0.86 [0.62-1.19],0.3572458911903118
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22616,62,nan [nan-nan],
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",22814,260,nan [nan-nan],
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",22821,267,nan [nan-nan],
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",23227,673,0.95 [0.87-1.04],0.2474547535516461
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22607,53,0.88 [0.65-1.20],0.4314231429533323
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,24774,1035,1.10 [1.03-1.18],0.0071187153082773
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26555,289,1.05 [0.92-1.19],0.5051370141930761
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27286,107,0.97 [0.78-1.21],0.789612534999754
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27729,89,0.93 [0.73-1.18],0.5328464438776259
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Rectum,27514,57,1.37 [1.04-1.82],0.0271775654487089
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27725,70,0.95 [0.72-1.24],0.685612899624258
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Stomach,27773,55,1.01 [0.74-1.36],0.9654962481529747
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm,27546,274,1.05 [0.92-1.20],0.5033974736650201
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27720,111,1.06 [0.86-1.31],0.5725806690745703
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27721,105,0.97 [0.78-1.20],0.7782979800014248
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27653,71,0.95 [0.73-1.24],0.7034087010411354
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma, any site",27655,70,0.97 [0.75-1.27],0.835558512811317
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi,27562,272,1.11 [0.97-1.27],0.1197335301121868
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,27732,122,1.18 [0.97-1.43],0.0987990181606753
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Other benign neoplasms of skin,27619,229,1.06 [0.92-1.23],0.4115879137814677
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of breast,27709,138,0.92 [0.76-1.11],0.3809105170265435
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Leiomyoma of uterus,27199,1001,1.03 [0.96-1.10],0.4687262943814574
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26360,275,1.17 [1.03-1.34],0.0168649990895917
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26081,451,1.17 [1.05-1.29],0.0033981684034644
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26081,451,1.17 [1.05-1.29],0.0033981684034644
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),24534,423,1.06 [0.95-1.18],0.288296409850567
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27199,98,0.79 [0.63-0.99],0.0445316337199338
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27417,105,1.15 [0.93-1.43],0.1878631346640459
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23030,931,1.08 [1.00-1.17],0.045085398145485
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,25424,909,1.02 [0.95-1.10],0.6187494813867553
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,25906,120,1.00 [0.82-1.22],0.9925993562441312
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26750,61,1.03 [0.77-1.37],0.8514509731556641
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25894,108,1.01 [0.82-1.25],0.9109303633814364
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26206,420,1.13 [1.01-1.27],0.0292848193475716
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26196,410,1.14 [1.02-1.27],0.0260579937090763
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25674,199,1.02 [0.86-1.21],0.8083935277369546
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25677,196,1.03 [0.87-1.23],0.7243086747641592
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22832,733,1.07 [0.98-1.17],0.1106427071617983
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22183,84,1.09 [0.85-1.39],0.4972417504799308
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,22778,679,1.06 [0.97-1.16],0.1802393829041696
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22150,51,1.23 [0.91-1.67],0.1867480801497023
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",22172,73,1.10 [0.85-1.42],0.4889842168571174
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Any mental disorder,23431,625,1.03 [0.94-1.13],0.4825073272784393
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",22927,121,0.98 [0.79-1.20],0.8228313522227111
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27531,81,0.86 [0.67-1.12],0.2652225718423445
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27572,49,0.80 [0.58-1.12],0.1968412945893404
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,26316,39,0.92 [0.64-1.32],0.6477261789977502
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",27723,39,0.91 [0.63-1.30],0.594714664087368
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",22845,39,0.92 [0.64-1.33],0.6716946805772082
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Alcohol dependence,26303,26,0.75 [0.47-1.19],0.2251679766630109
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Smoking dependency,26196,36,1.05 [0.72-1.54],0.7951947412011067
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22849,43,0.88 [0.62-1.25],0.4713492921334848
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",23192,386,1.06 [0.94-1.18],0.3515500568331325
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Depression,25765,342,1.05 [0.93-1.18],0.427833062392613
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Depression or dysthymia,22971,300,1.10 [0.97-1.25],0.151562045454058
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",22957,151,1.11 [0.93-1.33],0.2499703432459796
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Other anxiety disorders,25837,77,0.95 [0.73-1.23],0.6899588118161791
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Neurological diseases,23939,1641,1.07 [1.01-1.13],0.0277844361524132
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,21894,183,1.08 [0.92-1.27],0.3697074564904922
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27578,153,1.07 [0.89-1.28],0.4704879956623239
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26424,427,1.03 [0.92-1.14],0.6499254986481943
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Epilepsy,26137,140,1.01 [0.84-1.22],0.8899676664959738
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Migraine,26126,129,1.04 [0.85-1.26],0.7113852382284049
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27325,119,1.04 [0.85-1.27],0.6934893326552327
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27063,59,1.17 [0.88-1.56],0.270469897540369
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other sleep disorders,26094,97,0.96 [0.77-1.21],0.7426553427193658
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Sleep apnoea,27353,70,0.95 [0.73-1.24],0.7064777732428129
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26376,867,1.06 [0.98-1.14],0.1551175703808467
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25632,123,1.03 [0.85-1.26],0.7405213857469966
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26063,554,1.05 [0.96-1.16],0.2894627639246935
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27512,78,1.09 [0.85-1.39],0.5188492590457535
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Hemiplegia,27492,58,1.04 [0.78-1.39],0.782724749375852
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other neurological diseases,27279,124,0.92 [0.76-1.13],0.4457372740238038
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27025,426,1.01 [0.91-1.13],0.856544087621053
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26850,251,1.04 [0.90-1.20],0.5890237620637808
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26671,72,0.89 [0.68-1.16],0.3865766713037057
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26735,136,1.06 [0.88-1.29],0.5265677525879249
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26705,106,1.20 [0.97-1.48],0.0970671772983141
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23603,179,1.05 [0.88-1.24],0.590073099461985
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23837,413,1.05 [0.94-1.18],0.3737641326800915
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,26718,189,1.14 [0.97-1.33],0.1194966689395288
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27502,35,1.25 [0.87-1.80],0.2265812028551285
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1794,35,1.20 [0.82-1.75],0.3433288909220746
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",25743,35,1.26 [0.88-1.82],0.2055445010152062
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27066,97,1.15 [0.92-1.44],0.218378741115951
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27023,54,1.27 [0.94-1.70],0.1136892836201218
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",26928,97,1.03 [0.83-1.29],0.779780617749461
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27189,106,1.00 [0.81-1.25],0.9743618257478698
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27649,131,1.16 [0.96-1.40],0.1280627678650691
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,26966,106,0.96 [0.78-1.20],0.7336714698415341
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20441,2827,1.08 [1.03-1.14],0.0016058582275178
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27188,76,0.83 [0.64-1.07],0.1562165826258062
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21467,2083,1.10 [1.04-1.17],0.0004310633470586
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertension,21489,2105,1.10 [1.04-1.16],0.0005241169744688
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19436,52,1.15 [0.84-1.56],0.3840456246792721
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26071,737,1.05 [0.96-1.14],0.2833680882922909
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Angina pectoris,25844,510,1.02 [0.92-1.13],0.7136669203594828
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27094,150,1.01 [0.84-1.22],0.8891744556340027
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27175,231,1.06 [0.91-1.23],0.4563340990990806
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27703,28,1.38 [0.93-2.06],0.113757430509171
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25433,99,1.09 [0.87-1.36],0.4565670946935238
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,25811,489,1.07 [0.96-1.18],0.2023956372960333
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,26977,99,1.29 [1.04-1.60],0.0201002997825016
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27078,217,1.14 [0.98-1.32],0.0932649508378621
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,26975,97,0.85 [0.68-1.07],0.1683448650930695
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,26975,97,0.85 [0.68-1.07],0.1683448650930695
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19478,94,0.88 [0.70-1.12],0.3026078841242561
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,24117,40,1.18 [0.84-1.67],0.3457291537399367
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Conduction disorders,24158,81,1.06 [0.83-1.35],0.6499062708336405
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16658,102,1.08 [0.87-1.34],0.5051834431088671
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16835,279,0.89 [0.78-1.03],0.1075718773652996
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,24129,52,1.04 [0.76-1.41],0.8264166037822813
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,24135,58,0.84 [0.62-1.13],0.2559790251454786
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",26917,104,1.16 [0.93-1.44],0.1770203336655958
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",26980,130,0.92 [0.76-1.12],0.4290276114253996
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27020,98,0.95 [0.76-1.19],0.6448110475365161
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27090,86,0.97 [0.76-1.23],0.7847470921920398
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26776,73,1.05 [0.81-1.35],0.7374420357866981
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26817,114,0.95 [0.77-1.18],0.6659992875710554
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26134,132,1.08 [0.89-1.32],0.4161389709416956
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26107,105,1.11 [0.89-1.38],0.3420281291117131
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27556,102,1.10 [0.89-1.37],0.3718324907354129
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Varicose veins,26618,616,0.92 [0.84-1.01],0.0872516117440119
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypotension,26617,95,1.01 [0.81-1.27],0.9167874316686204
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22565,2125,1.07 [1.02-1.13],0.0062984971798788
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27556,127,1.08 [0.89-1.31],0.4519181748282193
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,26113,200,1.07 [0.92-1.25],0.3784350061700589
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26093,180,1.10 [0.93-1.30],0.2545736599428767
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,26856,234,0.97 [0.83-1.12],0.645839822757214
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,26848,226,0.96 [0.83-1.11],0.5783544507347891
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26998,564,1.02 [0.93-1.12],0.6487562464950021
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,26548,114,1.10 [0.90-1.35],0.3544957502761781
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Nasal polyp,26516,82,1.03 [0.81-1.32],0.8048420065950429
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26792,358,1.02 [0.91-1.15],0.681971526476219
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,26574,140,0.97 [0.80-1.17],0.7164026546948667
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13376,66,0.91 [0.69-1.21],0.5315097499348593
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,24785,1178,1.10 [1.03-1.18],0.0031796104288159
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Early onset COPD,26702,161,1.19 [1.00-1.42],0.0501257388754282
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26719,178,1.14 [0.96-1.34],0.1347060361537638
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26719,178,1.14 [0.96-1.34],0.1347060361537638
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25698,1016,1.09 [1.02-1.17],0.0131101031255488
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Asthma,20623,1016,1.11 [1.03-1.19],0.0051168359918439
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",20431,1016,1.11 [1.03-1.19],0.0046496926179648
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",20607,1000,1.10 [1.02-1.18],0.0126460199460033
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27440,84,0.92 [0.72-1.17],0.4983956896873551
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,25961,63,0.95 [0.71-1.26],0.7064527651461794
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27517,63,0.95 [0.72-1.26],0.7177317503228478
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,25954,56,0.87 [0.65-1.18],0.3794447343097193
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pleural effusion,25901,89,0.97 [0.76-1.23],0.788082102360901
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,26007,195,1.03 [0.88-1.21],0.6898411969422689
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,26585,93,1.05 [0.84-1.33],0.648253743692726
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19218,6056,1.03 [1.00-1.07],0.0657953859235371
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27198,471,1.07 [0.96-1.18],0.2039442908732702
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27727,105,1.02 [0.83-1.27],0.8289065828045545
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Impacted teeth,27732,95,1.07 [0.86-1.34],0.5478544949034214
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Dental caries,26832,105,1.03 [0.83-1.29],0.7565674390463126
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26845,118,1.09 [0.89-1.33],0.4103589080832784
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27718,116,1.04 [0.85-1.28],0.7054282198922486
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26843,116,1.13 [0.92-1.38],0.2381135692753472
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26543,81,0.89 [0.69-1.14],0.3558475928947018
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27637,51,0.83 [0.60-1.13],0.236199291734078
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,20954,220,0.94 [0.81-1.09],0.4185863816905982
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23082,2348,1.01 [0.97-1.07],0.572142789686768
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophagitis,21027,293,1.22 [1.08-1.39],0.0018955759526592
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21485,751,1.01 [0.93-1.10],0.7442216895454481
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20813,79,1.11 [0.87-1.42],0.4059838286911266
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20869,135,1.11 [0.91-1.34],0.3027341683448984
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20776,42,1.11 [0.79-1.57],0.5336444996905549
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastric ulcer,20880,146,0.93 [0.77-1.12],0.4210277166644388
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,20809,75,0.92 [0.71-1.19],0.5115700584637644
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27680,53,0.80 [0.59-1.10],0.1764434497510607
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Chronic gastritis,20870,136,0.97 [0.80-1.17],0.7409508042190233
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21592,858,1.00 [0.93-1.08],0.9935049425154948
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of appendix,27606,146,1.04 [0.86-1.24],0.6987920731611694
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,21317,583,0.98 [0.89-1.08],0.6554446362701185
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,20914,180,1.06 [0.90-1.25],0.4799312994131829
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27639,143,1.00 [0.83-1.20],0.965742820303284
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute appendicitis,27576,116,0.97 [0.79-1.19],0.7434227539327174
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Hernia,24839,1209,1.07 [1.00-1.14],0.0582696727663157
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Inguinal hernia,23697,67,0.85 [0.64-1.12],0.2379869952981891
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Umbilical hernia,23701,71,1.22 [0.94-1.58],0.1422177910714427
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ventral hernia,23740,110,1.02 [0.82-1.26],0.8472600343782675
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24598,968,1.08 [1.00-1.16],0.0366687503389098
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26677,922,1.05 [0.97-1.13],0.2045718048626127
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,21978,2208,1.03 [0.98-1.08],0.2811725636074947
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27416,64,1.06 [0.81-1.40],0.6648142987103318
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27698,92,0.97 [0.77-1.22],0.79564438527238
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn disease,25847,92,0.98 [0.77-1.23],0.8353864719533562
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25822,67,0.91 [0.69-1.20],0.507473364122418
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",27618,132,1.14 [0.94-1.38],0.1817270363726457
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,25887,132,1.14 [0.94-1.38],0.1693424337630787
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25873,118,1.13 [0.92-1.38],0.2425430569422216
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26537,782,1.05 [0.97-1.14],0.1933246371364237
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26526,771,1.05 [0.97-1.14],0.2422147286116409
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19875,105,0.98 [0.79-1.22],0.8471229045629824
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal stricture,27290,105,0.97 [0.78-1.21],0.7959892455818369
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19836,66,0.98 [0.74-1.29],0.8691365484616453
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20455,685,1.03 [0.94-1.12],0.5250351508884725
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20018,248,1.09 [0.95-1.25],0.2302724636424061
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,20168,398,1.10 [0.99-1.23],0.0775089658328083
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Constipation,26034,355,1.08 [0.96-1.22],0.1786561079709517
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27242,121,1.04 [0.85-1.27],0.7036347414366118
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19896,126,1.05 [0.86-1.27],0.6497411497775234
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19817,47,0.87 [0.63-1.21],0.4145443245120722
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20664,894,1.03 [0.95-1.11],0.5231548254333505
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,20003,233,0.92 [0.79-1.07],0.2863859072712171
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27224,103,1.00 [0.80-1.25],0.995972174408944
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of liver,26959,105,0.77 [0.61-0.96],0.0200344704020808
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of liver,26908,54,0.84 [0.61-1.14],0.2578110566215759
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26178,885,1.04 [0.97-1.13],0.2729315257622114
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholelithiasis,26034,741,1.04 [0.96-1.13],0.3485161943595024
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholecystitis,25426,133,1.19 [0.98-1.44],0.0716829527164502
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25362,69,1.00 [0.76-1.30],0.9780820902221838
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,25355,62,1.02 [0.77-1.35],0.8952657876783906
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),27611,62,1.01 [0.76-1.34],0.9452189477099704
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26368,314,1.14 [1.01-1.29],0.0368312041183158
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26159,105,1.22 [0.99-1.51],0.0634075735494138
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Coeliac disease,26143,89,1.24 [0.99-1.56],0.0608342403156445
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26095,41,1.09 [0.78-1.54],0.6068467852727133
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26227,173,1.15 [0.97-1.36],0.0999684549194796
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,GI-bleeding,26217,163,1.14 [0.96-1.35],0.1398466092310249
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,24567,1633,0.97 [0.91-1.03],0.2734404226769056
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27299,115,0.98 [0.79-1.20],0.811941870330258
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27307,460,0.98 [0.88-1.08],0.639602911264691
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26167,699,1.02 [0.93-1.11],0.719343191856322
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26935,327,0.93 [0.82-1.05],0.2610729702073714
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26680,72,0.84 [0.64-1.10],0.2040836656566516
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26815,207,0.92 [0.78-1.08],0.29712058510766
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27472,94,1.11 [0.89-1.39],0.3538970858158199
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27444,66,1.14 [0.87-1.48],0.3535934689103354
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27430,52,1.10 [0.81-1.49],0.529351636965141
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27492,57,0.82 [0.61-1.11],0.203135615196739
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27489,54,0.82 [0.60-1.12],0.2101822162749796
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26906,59,1.17 [0.88-1.55],0.2876050663417224
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27206,359,0.96 [0.85-1.08],0.466815599709891
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25571,103,1.07 [0.86-1.33],0.5208977083261102
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25623,155,0.86 [0.72-1.03],0.111594009813912
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25580,112,0.91 [0.74-1.13],0.4046621253403282
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25724,256,1.02 [0.89-1.17],0.8114015151219216
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25699,231,0.99 [0.85-1.14],0.8646997069181422
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19558,4433,1.04 [1.00-1.08],0.0621406404528295
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21305,2551,1.05 [1.00-1.10],0.0568308989083971
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,24935,1343,1.09 [1.03-1.16],0.0043520779747288
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18965,211,1.17 [1.01-1.37],0.0372833156402155
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19276,522,1.08 [0.98-1.20],0.1121586093191282
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27182,203,1.17 [1.01-1.37],0.0405569797647959
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27199,185,1.16 [0.98-1.36],0.0790892512556249
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19995,1241,1.09 [1.02-1.17],0.0106856532697527
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",22723,1241,1.09 [1.02-1.17],0.0117097298765764
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18767,13,0.91 [0.47-1.75],0.7844981846976905
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27559,13,0.85 [0.44-1.63],0.6277308791961347
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19036,282,1.07 [0.93-1.22],0.3499491006499555
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18843,89,0.95 [0.74-1.21],0.6611250933649071
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19060,306,1.18 [1.04-1.34],0.0116540522033379
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27569,155,1.29 [1.08-1.53],0.0049936670328957
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19242,488,1.07 [0.96-1.18],0.2355311074840658
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19250,496,1.05 [0.95-1.16],0.3551247480418604
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20177,1423,1.01 [0.95-1.08],0.7003111203476213
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18862,108,1.06 [0.85-1.31],0.6060276796503326
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19178,424,0.97 [0.87-1.09],0.6454338867395967
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18836,82,0.97 [0.76-1.25],0.810295790359024
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18860,106,1.05 [0.84-1.30],0.6788618918047895
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19124,370,1.03 [0.92-1.16],0.6232182988451448
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19067,313,1.04 [0.92-1.18],0.5153145975494773
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20678,300,1.00 [0.88-1.14],0.9666882902185794
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26931,218,1.01 [0.87-1.17],0.9291951948306624
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,26808,95,1.32 [1.06-1.65],0.0128918128973373
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,23747,81,1.00 [0.78-1.29],0.9795101355508242
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,23972,306,0.90 [0.79-1.03],0.1336161397427301
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,24698,1032,0.93 [0.87-1.00],0.0575845535010865
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,23882,216,0.91 [0.78-1.06],0.2222158945023322
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23743,77,0.94 [0.73-1.22],0.6618095354500206
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",24492,826,0.95 [0.88-1.03],0.2066104893182802
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23718,52,1.05 [0.77-1.43],0.7558963460106078
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,23913,247,1.00 [0.87-1.16],0.9620671551895428
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23771,105,1.02 [0.82-1.27],0.8294776281091002
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23757,91,0.87 [0.69-1.11],0.2669619850903532
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,23831,165,0.90 [0.76-1.08],0.2642954109279513
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23743,77,0.97 [0.75-1.25],0.7932704986779338
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24021,355,0.99 [0.88-1.12],0.9201157549223103
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,23979,387,1.02 [0.91-1.14],0.7432225660018826
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23666,74,0.89 [0.69-1.16],0.3942253075329587
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23702,110,0.88 [0.71-1.09],0.2529246240623826
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23737,145,1.13 [0.95-1.36],0.1744093897867568
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23631,39,1.07 [0.75-1.52],0.7022166948606279
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23651,59,1.02 [0.77-1.37],0.8693330161590167
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23635,43,0.88 [0.62-1.24],0.452310377152017
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,23869,277,1.12 [0.98-1.28],0.0865074008560336
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23650,58,1.01 [0.75-1.35],0.944573500263351
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23661,69,1.09 [0.84-1.43],0.513152869712501
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23729,137,1.22 [1.01-1.47],0.0354690250465043
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23673,81,0.86 [0.67-1.11],0.2515449500142861
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24134,542,1.09 [0.99-1.20],0.068490817689208
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,23784,192,0.96 [0.81-1.13],0.5944297315330703
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,23883,291,1.09 [0.96-1.24],0.2042484807346827
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,25006,239,0.93 [0.81-1.08],0.3538100502775154
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,25258,491,0.88 [0.79-0.98],0.0152566415977051
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24806,39,0.83 [0.58-1.20],0.3213364493906214
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24835,68,0.81 [0.61-1.06],0.1302431289816256
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,24886,119,0.84 [0.68-1.04],0.1054530974836821
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,22656,6173,0.99 [0.96-1.02],0.580895866441794
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,25276,206,1.21 [1.04-1.40],0.0154952147963066
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25116,46,1.50 [1.10-2.04],0.0104674832660866
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,25446,38,1.63 [1.16-2.29],0.0051717033022898
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,25457,49,1.21 [0.88-1.65],0.2331681241514647
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25452,44,1.39 [1.01-1.92],0.0407703424217269
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27522,134,0.88 [0.72-1.07],0.1880312502597706
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27395,69,1.11 [0.85-1.45],0.4403430147404749
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27490,102,0.92 [0.74-1.15],0.4720925227781531
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27425,37,0.77 [0.53-1.12],0.1690587133734626
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,25508,1261,1.01 [0.95-1.08],0.7578860900140543
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Cystitis,24385,138,0.98 [0.81-1.18],0.809225835986908
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,24332,85,1.10 [0.86-1.39],0.4520546263140631
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24417,170,1.03 [0.87-1.23],0.7073971719212573
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,24335,88,0.94 [0.74-1.19],0.6086039100211277
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25238,991,1.03 [0.96-1.11],0.3530302513245557
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27451,482,0.93 [0.84-1.03],0.1833569794017373
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27116,147,0.92 [0.76-1.10],0.3476837477949522
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,27139,170,0.94 [0.79-1.11],0.4634088024629225
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27086,117,0.93 [0.76-1.15],0.518764106277821
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27387,565,0.96 [0.88-1.06],0.4569068477334125
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,26957,135,0.88 [0.72-1.06],0.1815628323744593
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27074,252,1.01 [0.88-1.17],0.836434651383926
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,25312,4613,1.00 [0.96-1.03],0.8257236423656431
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,21062,363,1.13 [1.01-1.27],0.0377376527722579
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20794,95,1.27 [1.02-1.59],0.0322478269841329
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20869,170,1.13 [0.95-1.33],0.1664918483508014
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21497,798,1.06 [0.98-1.15],0.1254937870577783
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21105,406,0.97 [0.87-1.08],0.5606713508446737
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21666,967,0.94 [0.87-1.01],0.1019207456256487
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,21017,318,0.87 [0.77-0.99],0.0314888964282
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21138,439,1.02 [0.92-1.14],0.6946314131548331
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20800,101,1.01 [0.81-1.26],0.924391030413334
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20885,186,1.05 [0.90-1.24],0.5316033565746562
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27725,264,1.11 [0.97-1.27],0.1310956369047295
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27737,250,1.10 [0.96-1.26],0.175983744546331
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27763,141,1.17 [0.98-1.41],0.08238061526549
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27752,155,1.19 [1.00-1.41],0.0542581643137514
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20843,144,0.96 [0.80-1.16],0.7069441174387112
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20811,112,1.01 [0.82-1.25],0.9069313605000132
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20840,141,1.11 [0.92-1.34],0.2627964580454757
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,27656,469,1.11 [1.01-1.23],0.0377044486591989
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",22046,1347,1.02 [0.95-1.08],0.6129295610794078
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21580,881,0.99 [0.92-1.07],0.8943125733374597
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27743,197,1.05 [0.90-1.23],0.5119167974669644
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21167,468,0.94 [0.85-1.04],0.2529501124202088
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,21030,331,0.98 [0.86-1.11],0.7129655502084034
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21599,900,0.95 [0.88-1.03],0.2316199469072234
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Female infertility,20814,115,1.08 [0.88-1.33],0.4729049406016821
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20807,108,1.05 [0.85-1.30],0.6485917435323806
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27761,877,0.99 [0.91-1.07],0.7355533045668431
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27765,1203,1.00 [0.93-1.08],0.9461201077368576
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27762,479,1.02 [0.92-1.13],0.7317778329372927
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,27418,135,0.94 [0.77-1.14],0.5280915047396746
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,27473,190,0.97 [0.82-1.14],0.7078822267677607
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,27449,166,1.08 [0.91-1.28],0.4006074029757545
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27779,164,0.92 [0.77-1.10],0.3601104659233873
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27781,161,0.92 [0.77-1.10],0.3568578694750721
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27778,415,0.89 [0.80-1.00],0.0532271779832192
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,27488,125,0.72 [0.58-0.88],0.0019098300838818
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27593,230,0.92 [0.79-1.08],0.3098289984336037
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,27030,146,1.02 [0.84-1.23],0.8735643263186534
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,27084,200,0.88 [0.75-1.04],0.1321162036236897
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,27132,248,0.95 [0.82-1.10],0.472818465836374
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,27030,146,1.01 [0.84-1.22],0.929927839314716
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,27022,138,1.01 [0.84-1.23],0.880282989688749
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,27033,149,0.86 [0.71-1.04],0.1202461315071349
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26793,231,1.03 [0.89-1.20],0.7074172455976008
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],26996,434,0.98 [0.87-1.09],0.6637918493654424
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,27235,673,1.02 [0.93-1.12],0.6423922597691312
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27782,170,1.05 [0.89-1.25],0.5472747483537164
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,26325,128,0.96 [0.79-1.18],0.7103240986964672
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26664,102,0.99 [0.79-1.24],0.9456574339352986
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27791,341,0.88 [0.78-1.00],0.0550721453242014
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27711,261,0.86 [0.74-0.99],0.0346484314821069
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27777,251,1.09 [0.95-1.26],0.2332195946887865
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27768,242,1.10 [0.95-1.27],0.2073406736090685
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27485,45,0.85 [0.61-1.19],0.3480755750476907
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,24849,654,0.92 [0.85-1.01],0.0831885733802585
